Skip to main content
. 2015 Sep 4;6(30):28539–28555. doi: 10.18632/oncotarget.5164

Table 1. Clinical features of EAE in mice in the administration of vehicle, tIL12rβ1/Fc or CsA.

Group Treatment regimen Preventive regimen
Incidence, % Mean maximal score Incidence, % Mean maximal score
Vehicle 100 3.25 ± 0.35 100 2.95 ± 0.44
tIL12rβ1/Fc 100 1.90 ± 0.46*** 70 1.10 ± 0.62***
CsA 100 2.30 ± 0.43*** 80 1.20 ± 0.75***

Values are expressed as mean ± SD

***

p < 0.001 compared with vehicle control.